Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAMSON: Statin Side-effects Or Nocebo
NCT02668016Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Mar 2016
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in hyperlipidemia, cardiovascular disease (CVD), sponsored by Imperial College London. Started Mar 2016; status: completed.
02
Drugs
atorvastatin
03
Conditions
hyperlipidemiacardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02668016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02668016.